These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36046040)

  • 21. Caerin 1 Peptides, the Potential Jack-of-All-Trades for the Multiple Antibiotic-Resistant Bacterial Infection Treatment and Cancer Immunotherapy.
    Xiao L; Yang X; Li J; Zhang P; Tang S; Cao D; Chen S; Li H; Zhang W; Chen G; Ni G; Wang T; Liu X
    Biomed Res Int; 2022; 2022():7841219. PubMed ID: 35445137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long noncoding HOXA11-AS knockdown suppresses the progression of non-small cell lung cancer by regulating miR-3619-5p/SALL4 axis.
    Xia H; Niu Q; Ding Y; Zhang Z; Yuan J; Jin W
    J Mol Histol; 2021 Aug; 52(4):729-740. PubMed ID: 34050851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The membrane-active amphibian peptide caerin 1.8 inhibits fibril formation of amyloid β1-42.
    Liu Y; Wang T; Calabrese AN; Carver JA; Cummins SF; Bowie JH
    Peptides; 2015 Nov; 73():1-6. PubMed ID: 26275335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic effect of 188Re-MAG3-depreotide on non-small cell lung cancer in vivo and in vitro.
    Yu F; Lv M; Cai H; Li D; Yuan X; Lv Z
    Int J Clin Exp Pathol; 2013; 6(3):421-30. PubMed ID: 23411669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intratumoral injection of caerin 1.1 and 1.9 peptides increases the efficacy of vaccinated TC-1 tumor-bearing mice with PD-1 blockade by modulating macrophage heterogeneity and the activation of CD8
    Ni G; Yang X; Li J; Wu X; Liu Y; Li H; Chen S; Fogarty CE; Frazer IH; Chen G; Liu X; Wang T
    Clin Transl Immunology; 2021; 10(8):e1335. PubMed ID: 34429969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of lathyrol derivatives on non-small cell lung cancer and the possible mechanism.
    Yan Y; Zhou W; Guo Q; Zhang H; Ji H; Yang L; Zhang J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 47(2):143-152. PubMed ID: 35545404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: in vitro and in vivo studies.
    Xue X; Sun DF; Sun CC; Liu HP; Yue B; Zhao CR; Lou HX; Qu XJ
    Lung Cancer; 2012 Jun; 76(3):300-8. PubMed ID: 22261315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polyoxometalate SbW9 regulates proliferation and apoptosis of NSCLC cells via PTEN-dependent AKT signaling pathway.
    Sun HB; Xu L; Wang ZX; Zheng Y; Zhao Y; Yin YY; Han XL; Xu ZN
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7959-7967. PubMed ID: 31599421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quercetin inhibits proliferation of and induces apoptosis in non-small-cell lung carcinoma via the lncRNA SNHG7/miR-34a-5p pathway.
    Chai R; Xu C; Lu L; Liu X; Ma Z
    Immunopharmacol Immunotoxicol; 2021 Dec; 43(6):693-703. PubMed ID: 34448661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-138 inhibits proliferation by targeting 3-phosphoinositide-dependent protein kinase-1 in non-small cell lung cancer cells.
    Ye XW; Yu H; Jin YK; Jing XT; Xu M; Wan ZF; Zhang XY
    Clin Respir J; 2015 Jan; 9(1):27-33. PubMed ID: 24405893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinesin superfamily protein 21B acts as an oncogene in non-small cell lung cancer.
    Sun ZG; Pan F; Shao JB; Yan QQ; Lu L; Zhang N
    Cancer Cell Int; 2020; 20():233. PubMed ID: 32536821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pifithrin-μ is efficacious against non-small cell lung cancer via inhibition of heat shock protein 70.
    Zhou Y; Ma J; Zhang J; He L; Gong J; Long C
    Oncol Rep; 2017 Jan; 37(1):313-322. PubMed ID: 28004121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hsa_circ_0017639 regulates cisplatin resistance and tumor growth via acting as a miR-1296-5p molecular sponge and modulating sine oculis homeobox 1 expression in non-small cell lung cancer.
    Chang F; Li J; Sun Q; Wei S; Song Y
    Bioengineered; 2022 Apr; 13(4):8806-8822. PubMed ID: 35287543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticancer mechanism of breviscapine in non-small cell lung cancer A549 cells acts via ROS-mediated upregulation of IGFBP4.
    Wei W; Wang L; Xu L; Zeng J
    J Thorac Dis; 2021 Apr; 13(4):2475-2485. PubMed ID: 34012594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bu-Fei decoction and modified Bu-Fei decoction inhibit the growth of non-small cell lung cancer, possibly via inhibition of apurinic/apyrimidinic endonuclease 1.
    Jiang ST; Han SY; Pang LN; Jiao YN; He XR; Li PP
    Int J Mol Med; 2018 Apr; 41(4):2128-2138. PubMed ID: 29393411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells.
    Moody TW; Switzer C; Santana-Flores W; Ridnour LA; Berna M; Thill M; Jensen RT; Sparatore A; Del Soldato P; Yeh GC; Roberts DD; Giaccone G; Wink DA
    Lung Cancer; 2010 May; 68(2):154-60. PubMed ID: 19628293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased efficacy of gefitinib on cisplatin-resistant wild-type epidermal growth factor receptor non-small cell lung cancer cells.
    Li A; Cao W; Liu X; Zhang Y; Ma Y; Xu R; Tang X
    Transl Cancer Res; 2020 Sep; 9(9):5473-5483. PubMed ID: 35117912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
    Pang L; Han S; Jiao Y; Jiang S; He X; Li P
    Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LINC00518 Interference Inhibits Non-Small Cell Lung Cancer by Upregulating miR216b-5p Expression.
    Ren Y; Zhu H; Han S
    Cancer Manag Res; 2020; 12():11041-11050. PubMed ID: 33173337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth inhibition of non-small-cell lung carcinoma by BN/GRP antagonist is linked with suppression of K-Ras, COX-2, and pAkt.
    Hohla F; Schally AV; Kanashiro CA; Buchholz S; Baker B; Kannadka C; Moder A; Aigner E; Datz C; Halmos G
    Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18671-6. PubMed ID: 18003891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.